Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, February 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 265 articles:
HTML format


 

Single Articles

  1. ASSEFA AA, Feleke T, G/Tsadik SA, Degela F, et al
    Utilization and associated factors of cervical cancer screening service among eligible women attending maternal health services at Adare General Hospital, Hawassa city, Southern Ethiopia.
    Sci Rep. 2024;14:2774.
    PubMed    
    Abstract available

  2. GORI S, Frayle H, Pagan A, Solda M, et al
    Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
    Fam Med Community Health. 2024;12.
    PubMed    
    Abstract available

  3. BRAUTIGAM K, Schmidt T, Baur M, Tauber N, et al
    Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
    Anticancer Res. 2024;44:503-510.
    PubMed    
    Abstract available

  4. JIA C, Wu Y, Gao F, Liu W, et al
    The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions.
    Free Radic Biol Med. 2024 Jan 31:S0891-5849(24)00051.
    PubMed    
    Abstract available

  5. RODRIGUEZ I, Rossi NM, Keskus AG, Xie Y, et al
    Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing.
    Am J Hum Genet. 2024 Jan 25:S0002-9297(24)00002.
    PubMed    
    Abstract available

  6. GU LN, Yu JW, Jiang L, Liu TB, et al
    Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Eur Rev Med Pharmacol Sci. 2024;28:668-678.
    PubMed    
    Abstract available

  7. LIN S, Chen Z, Li S, Chen B, et al
    Anti-tumor effect and mechanism of the total biflavonoid extract from S doederleinii on human cervical cancer cells in vitro and in vivo.
    Heliyon. 2024;10:e24778.
    PubMed    
    Abstract available

  8. ALSHEHRI HD, Alqudah O, Almadani FB, Aldalbahi AM, et al
    Factors Associated With the Uptake of Cervical Cancer Screening Among Family Medicine Physicians, Compared With Women of the Community in Riyadh, Saudi Arabia.
    Cureus. 2024;16:e53283.
    PubMed    
    Abstract available

  9. JUNG BC, Woo SH, Kim SH, Kim YS, et al
    Gefitinib induces anoikis in cervical cancer cells.
    BMB Rep. 2024 Feb 5:6127.
    PubMed    
    Abstract available

  10. SONG J, Pang W, Yi H, Ji J, et al
    Tumor and metastatic lymph nodes metabolic activity on (18)F-FDG-PET/CT to predict progression-free survival in locally advanced cervical cancer.
    Abdom Radiol (NY). 2024 Feb 1. doi: 10.1007/s00261-023-04158.
    PubMed    
    Abstract available

  11. LA SPINA S, Scollo P, Pecorino B, Lombardo V, et al
    Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
    Oncology (Williston Park). 2024;38:15-19.
    PubMed    
    Abstract available

  12. SARASWAT I, Goel A
    Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles.
    Anticancer Agents Med Chem. 2024.
    PubMed    
    Abstract available

  13. FOKOM DOMGUE J, Dille I, Kapambwe S, Yu R, et al
    HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Front Public Health. 2024;12:1343064.
    PubMed    
    Abstract available

  14. INTERNATIONAL EM
    Retracted: Analysis of the Clinical Value of MAGE-A9 Expressions in Cervical Cancer Tissues and PBMC.
    Emerg Med Int. 2024;2024:9758570.
    PubMed    
    Abstract available

  15. LI Z, Wei R, Yao S, Meng F, et al
    HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer.
    Heliyon. 2024;10:e24664.
    PubMed    
    Abstract available

  16. HUANG Z, Yao W, Zhong Z, Yang G, et al
    Chemotherapy alone versus chemotherapy plus (125)I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis.
    Heliyon. 2024;10:e24666.
    PubMed    
    Abstract available

  17. WANG X, Wang K, Wang X
    NUPR1 contributes to activate TFE3-dependent autophagy leading to cervical cancer proliferation.
    Heliyon. 2024;10:e24408.
    PubMed    
    Abstract available

  18. MA GF, Lin GL, Wang ST, Huang YY, et al
    Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
    BMC Womens Health. 2024;24:81.
    PubMed    
    Abstract available

  19. ALFRINK J, Aigner T, Zoche H, Distel L, et al
    Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures.
    Strahlenther Onkol. 2024 Jan 31. doi: 10.1007/s00066-023-02196.
    PubMed    
    Abstract available

  20. LI Z, Zhang J, You S, Zhang J, et al
    Pterostilbene upregulates MICA/B via the PI3K/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells.
    Exp Cell Res. 2024;435:113933.
    PubMed    
    Abstract available

  21. ZHANG YT, Xu LJ, Li L
    EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment.
    Genet Test Mol Biomarkers. 2024;28:10-21.
    PubMed    
    Abstract available

  22. BARTOSIK M, Moranova L, Izadi N, Strmiskova J, et al
    Advanced technologies towards improved HPV diagnostics.
    J Med Virol. 2024;96:e29409.
    PubMed    
    Abstract available


  23. Retraction: LINC00636 promotes lymph node metastasis and of cervical cancer through target NM23.
    Biosci Rep. 2024;44:BSR-2020-0367.
    PubMed    


  24. PATTERSON MR, Meijers AS, Ryder EL, Scarth JA, et al
    E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    bioRxiv. 2024 Jan 15:2024.01.08.574687. doi: 10.1101/2024.01.08.574687.
    PubMed    
    Abstract available

  25. BHATTACHARYA K, Chandra Nath B, Ahmed E, Khanal P, et al
    Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer.
    RSC Adv. 2024;14:4188-4200.
    PubMed    
    Abstract available

  26. PRATT R, Barsness CB, Lin J, Desai J, et al
    Integrating HPV self-collect into primary care to address cervical cancer screening disparities.
    Prev Med Rep. 2024;38:102599.
    PubMed    
    Abstract available

  27. MENG Q, Sun H, Zhang Y, Yang X, et al
    Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.
    J Exp Clin Cancer Res. 2024;43:36.
    PubMed    
    Abstract available

  28. DENNY L, Kataria I, Huang L, Schmeler KM, et al
    Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.
    Nature. 2024;626:30-32.
    PubMed    


  29. VOVK CAPITAL O, CYRILLICY, Holovanova IA, Podvin A, Popovuch IU, et al
    CONTEXTUAL FACTORS ASSOCIATED WITH CERVICAL CANCER.
    Wiad Lek. 2023;76:2687-2693.
    PubMed    
    Abstract available

  30. AMATYA VAIDYA S, Roka Magar L, Magar SB
    Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:658-661.
    PubMed    
    Abstract available

  31. SAPKOTA RP, Pokhrel S, Bhandari A, Adhikari P, et al
    Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient Department of Gynaecology of a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:699-702.
    PubMed    
    Abstract available

  32. WANG J, Wang X, Ma T, Lu Y, et al
    A visualization analysis of hotspots and global trends on pelvic floor dysfunction in cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:54.
    PubMed    
    Abstract available

  33. TRIPATHI T, Yadav J, Janjua D, Chaudhary A, et al
    Targeting Cervical Cancer Stem Cells by Phytochemicals.
    Curr Med Chem. 2024 Jan 29. doi: 10.2174/0109298673281823231222065616.
    PubMed    
    Abstract available

  34. VARGAS-SIERRA O, Hernandez-Juarez J, Uc-Uc PY, Herrera LA, et al
    Role of SLC5A8 as a Tumor Suppressor in Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:16.
    PubMed    
    Abstract available

  35. BIKORIMANA JP, Abusarah J, Goncalves M, Farah R, et al
    An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
    Cancer Sci. 2024 Jan 29. doi: 10.1111/cas.16096.
    PubMed    
    Abstract available

  36. DESAI KT, Hansen N, Rodriguez AC, Befano B, et al
    Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.
    Prev Med. 2024;180:107881.
    PubMed    
    Abstract available

  37. GONG Y, Luo G, Zhang S, Chen Y, et al
    Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Cell Signal. 2024 Jan 27:111068. doi: 10.1016/j.cellsig.2024.111068.
    PubMed    
    Abstract available

  38. KITTISIAM T, Chanpanitkitchot S, Tangjitgamol S, Srijaipracharoen S, et al
    Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer.
    Asian Pac J Cancer Prev. 2024;25:211-217.
    PubMed    
    Abstract available

  39. THAKUR N, Kaur H, Kaur S, Lehal P, et al
    Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
    Asian Pac J Cancer Prev. 2024;25:139-144.
    PubMed    
    Abstract available

  40. SINGARAM NK, Hulikal N, Manthri R, Chowhan AK, et al
    Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.
    Cureus. 2024;16:e53107.
    PubMed    
    Abstract available

  41. ALBAYAT SS, Mundodan JM, Elmardi K, Hasnain S, et al
    Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.
    Womens Health (Lond). 2024;20:17455057241227360.
    PubMed    
    Abstract available

  42. ANG DJM, Chan JJ
    Evolving standards and future directions for systemic therapies in cervical cancer.
    J Gynecol Oncol. 2024 Jan 15. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  43. AL-ANI A, Hammouri M, Sultan H, Al-Huneidy L, et al
    Factors affecting cervical screening using the health belief model during the last decade: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6275.
    PubMed    
    Abstract available

  44. EVINA BOLO S, Kenfack B, Wisniak A, Tankeu G, et al
    Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study.
    BMC Womens Health. 2024;24:76.
    PubMed    
    Abstract available

  45. CHEN Q, Zhao J, Xue X, Xie X, et al
    Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database.
    BMC Womens Health. 2024;24:75.
    PubMed    
    Abstract available

  46. HA JL, Kaser E, Guan T, Mayberry TG, et al
    Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
    Med Oncol. 2024;41:65.
    PubMed    
    Abstract available

  47. LE-TRUNG N, Kanaori K, Waku T, Dang TTP, et al
    Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
    BMC Complement Med Ther. 2024;24:59.
    PubMed    
    Abstract available

  48. QUAN Y, Zhou M, Li J, Yang Y, et al
    The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.
    Exp Cell Res. 2024 Jan 25:113924. doi: 10.1016/j.yexcr.2024.113924.
    PubMed    
    Abstract available

  49. BERZANSKY I, Reynolds CA, Charlton BM
    Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Cancer Causes Control. 2024 Jan 27. doi: 10.1007/s10552-023-01847.
    PubMed    
    Abstract available

  50. JARAMILLO L, Camussi E, Dotti M, Ferrante G, et al
    EuroMed Cancer Network contributions to eliminating cervical cancer in low- and middle-income Mediterranean countries.
    East Mediterr Health J. 2023;26:894-902.
    PubMed    
    Abstract available

  51. OKAYAMA K, Kakinuma M, Teruya K, Oda M, et al
    Predictive Value of Various Atypical Cells for the Detection of Human Papillomavirus in Cervical Smears.
    Int J Mol Sci. 2024;25:1212.
    PubMed    
    Abstract available

  52. QIN Y, Deng J, Ling Y, Chen T, et al
    Our experience diagnosing 225 patients with cervical glandular lesions: current technologies, lessons learned, and areas for improvement.
    Diagn Pathol. 2024;19:22.
    PubMed    
    Abstract available

  53. WU Q, Lou J, Liu J, Dong L, et al
    Performance of node reporting and data system (node-RADS): a preliminary study in cervical cancer.
    BMC Med Imaging. 2024;24:28.
    PubMed    
    Abstract available

  54. MURAHWA AT, Mudzviti T, Mandishora RSD, Chatindo T, et al
    Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
    Viruses. 2024;16:162.
    PubMed    
    Abstract available

  55. LI J, Xi J
    Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Genes (Basel). 2024;15:121.
    PubMed    
    Abstract available

  56. AZANGOU-KHYAVY M, Ghasemi E, Rezaei N, Khanali J, et al
    Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990-2019.
    BMC Womens Health. 2024;24:69.
    PubMed    
    Abstract available

  57. CASANOVA C, Madeira JIM, Pereira da Silva N, Antunes C, et al
    Post-radiation uterine rhabdomyosarcoma.
    BMJ Case Rep. 2024;17:e258853.
    PubMed    


  58. KELLEN E, Meers Z, Pil L, Goossens MC, et al
    Impact of altering the invitation package on screening participation among never-screeners in the Flemish population-based cancer screening programs.
    Eur J Cancer Prev. 2024;33:181-184.
    PubMed    
    Abstract available

  59. NIE L, Qin H, Li S, Yu Z, et al
    The establishment of a multiplex fluorescent polymerase chain reaction coupled with capillary electrophoresis analysis technology enables the simultaneous detection of 16 genotypes of human papillomavirus.
    J Clin Lab Anal. 2024;38.
    PubMed    
    Abstract available

  60. YU Y, Yu J, Cui X, Sun X, et al
    TNF-alpha-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin.
    J Antibiot (Tokyo). 2024;77:102-110.
    PubMed    
    Abstract available

  61. TOYOHARA Y, Taguchi A, Ishii Y, Yoshimoto D, et al
    Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.
    Cancer Sci. 2024;115:125-138.
    PubMed    
    Abstract available

  62. DARVISHI M, Nouri M, Zahir M, Asli M, et al
    Overview of Human Papillomavirus Infection.
    Infect Disord Drug Targets. 2024;24:e031123223107.
    PubMed    
    Abstract available

  63. JIBOC NM, Pasca A, Taut D, Baban AS, et al
    Factors influencing human papillomavirus vaccination uptake in European women and adolescents: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6242.
    PubMed    
    Abstract available

  64. WHEELER CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, et al
    Comparing the performance of two HPV assays for a new use indication: a real-world evidence-based evaluation in the United States.
    Am J Obstet Gynecol. 2023 Oct 6:S0002-9378(23)00730.
    PubMed    
    Abstract available

  65. SLAMA J, Dvorak V, Trnkova M, Skrivanek A, et al
    Is phased implementation of HPV testing and triage with dual staining the way to transform organized cytology screening?
    Eur J Cancer Prev. 2024;33:168-176.
    PubMed    
    Abstract available

  66. WANG S, Zhang S
    A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Reprod Sci. 2024;31:514-531.
    PubMed    
    Abstract available

  67. MONDRAGON MARQUEZ LI, Dominguez Bueso DL, Gonzalez Ruiz LM, Liu JJ, et al
    Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Cancer Causes Control. 2023;34:1073-1084.
    PubMed    
    Abstract available

  68. RIVERS G, Hinchliff S, Thompson J
    Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
    J Clin Nurs. 2024 Feb 9. doi: 10.1111/jocn.17023.
    PubMed    
    Abstract available

  69. MA F, Wang Q, Zhang D, Wang Z, et al
    Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis.
    Pharm Biol. 2024;62:170-182.
    PubMed    
    Abstract available

  70. YANG S, Zhang W, Liu C, Li C, et al
    Predictive value and potential association of PET/CT radiomics on lymph node metastasis of cervical cancer.
    Ann Med Surg (Lond). 2023;86:805-810.
    PubMed    
    Abstract available

  71. PIRANI N, Jafari M, Motlagh AG, Pourasghari H, et al
    Policy analysis of cervical cancer prevention in Iran based on the policy triangle model.
    J Educ Health Promot. 2023;12:381.
    PubMed    
    Abstract available

  72. ZHANG Z, Ma Q, Zhang L, Ma L, et al
    Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
    Front Cell Infect Microbiol. 2024;14:1325500.
    PubMed    
    Abstract available

  73. FERNANDEZ-DEAZA G, Serrano B, Roura E, Castillo JS, et al
    Cervical cancer screening coverage in the Americas region: a synthetic analysis.
    Lancet Reg Health Am. 2024;30:100689.
    PubMed    
    Abstract available

  74. OLTHOF EP, Bergink-Voorthuis BJ, Wenzel HHB, Mongula J, et al
    Diagnostic accuracy of MRI, CT, and [(18)F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer - a nationwide Dutch cohort study.
    Insights Imaging. 2024;15:36.
    PubMed    
    Abstract available

  75. ATNAFU DD, Khatri R, Assefa Y
    Drivers of cervical cancer prevention and management in sub-Saharan Africa: a qualitative synthesis of mixed studies.
    Health Res Policy Syst. 2024;22:21.
    PubMed    
    Abstract available

  76. FIGUEIREDO D, Ribeiro I, Penedones A, Mendes D, et al
    Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.
    BMC Womens Health. 2024;24:102.
    PubMed    


  77. ZHANG C, Yuan L, Zou Q, Shao C, et al
    CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA.
    Cell Mol Biol Lett. 2024;29:25.
    PubMed    
    Abstract available

  78. YANG X, Wang W, Li SH, Yang Z, et al
    A case of cervical cancer which metastasized to axillary lymph node and breast skin was documented.
    Asian J Surg. 2024 Feb 7:S1015-9584(24)00156.
    PubMed    


  79. PENG C, Li X, Tang W, Zhu W, et al
    Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study.
    Int Immunopharmacol. 2024;129:111578.
    PubMed    
    Abstract available

  80. HUO G, Liu W, Chen P
    Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer.
    J Gynecol Oncol. 2024 Jan 24. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  81. YUN BS, Lee KB, Lee KH, Chang HK, et al
    Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).
    J Gynecol Oncol. 2024 Jan 22. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  82. SCOTT AA, Vanderpuye V, Dadzie MA, Yarney J, et al
    Expanding Access to Computed Tomographic Staging and Three-Dimensional Intensity Modulated Radiotherapy for Cervical Cancer in Ghana.
    JCO Glob Oncol. 2024;10:e2300266.
    PubMed    
    Abstract available

  83. KAMIL SHAREEF NA, Zandsalimi F, Tavoosidana G
    Gold nanoparticles (AuNPs) decrease the viability of cervical cancer cells by inducing the BAX gene and activating antioxidant enzymes.
    Mol Biol Rep. 2024;51:287.
    PubMed    
    Abstract available

  84. FENG X, Meng X, Tang D, Guo S, et al
    Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer.
    Cancer Pathog Ther. 2023;2:38-49.
    PubMed    
    Abstract available

  85. JAFARI A, Farahani M, Abdollahpour-Alitappeh M, Manzari-Tavakoli A, et al
    Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells.
    Front Oncol. 2024;13:1277772.
    PubMed    
    Abstract available

  86. WANG J, Mou X, Lu H, Jiang H, et al
    Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Front Endocrinol (Lausanne). 2024;14:1302074.
    PubMed    
    Abstract available

  87. WANG YZ, Wang JS, Du J, Tang XL, et al
    Clinical benefit analysis of PD-1 inhibitors in patients with advanced, recurrent or metastatic cervical cancer: a meta-analysis and systematic review.
    Front Immunol. 2024;15:1305810.
    PubMed    
    Abstract available

  88. DAMSGAARD S, Allergodt K, Handberg C
    Women's experiences with opting out of cervical cancer screening and the role of the nurse in the women's decision-making process.
    J Clin Nurs. 2024 Feb 7. doi: 10.1111/jocn.17067.
    PubMed    
    Abstract available

  89. SONG Y, Zhang A, Zhou J, Luo Y, et al
    Overlapping cytoplasms segmentation via constrained multi-shape evolution for cervical cancer screening.
    Artif Intell Med. 2024;148:102756.
    PubMed    
    Abstract available

  90. PEDERSEN BT, Pedersen H, Serizawa R, Sonne SB, et al
    Cervical cancer screening activity in the Capital Region of Denmark before, during and after the COVID-19 pandemic.
    Prev Med. 2024 Feb 5:107888. doi: 10.1016/j.ypmed.2024.107888.
    PubMed    
    Abstract available

  91. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    PubMed    
    Abstract available

  92. NODE J, Dor F, Puget L, Ramanah R, et al
    Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott).
    J Med Virol. 2024;96:e29465.
    PubMed    
    Abstract available

  93. SPRINGER R, Erroba J, O'Malley JP, Huguet N, et al
    Differences in up-to-date colorectal and cervical cancer screening rates by ethnicity and preferred language: An analysis across patient-, clinic-, and area-level data sources.
    SSM Popul Health. 2024;25:101612.
    PubMed    
    Abstract available

  94. XIAO J, Wang L, Zhuang Y, Zhu Q, et al
    The deubiquitinase OTUB2 promotes cervical cancer growth through stabilizing FOXM1.
    Am J Transl Res. 2024;16:75-84.
    PubMed    
    Abstract available

  95. OKEKE SU
    Fighting cervical cancer in Africa: Taking a closer look at human papillomavirus 35.
    Afr J Lab Med. 2024;13:2243.
    PubMed    


  96. WANG P, An M, Zhang M, Yan X, et al
    Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review.
    Front Immunol. 2024;15:1301329.
    PubMed    
    Abstract available

  97. AKANDE OW, Akande TM
    Human Papillomavirus Vaccination amongst Students in a Tertiary Institution in North Central Nigeria: A Cross-sectional Study on Sociodemographic Factors Associated with Its Awareness, Uptake and Willingness to Pay.
    Niger Postgrad Med J. 2024;31:14-24.
    PubMed    
    Abstract available

  98. LURGAIN JG, Ouaarab-Essadek H, Mellouki K, Malik-Hameed S, et al
    Exploring self-care and cervical cancer prevention attitudes and practices among Moroccan and Pakistani immigrant women in Catalonia, Spain: a comparative qualitative study.
    BMC Public Health. 2024;24:388.
    PubMed    
    Abstract available

  99. PEERENBOOM R, Ackroyd S, Lee N
    The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions.
    Gynecol Oncol Rep. 2024;51:101328.
    PubMed    
    Abstract available

  100. EL RHABORI S, El Aissouq A, Daoui O, Elkhattabi S, et al
    Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations.
    Heliyon. 2024;10:e24551.
    PubMed    
    Abstract available

  101. ENDALE HT, Mariye YF, Negash HK, Hassen FS, et al
    MiRNA in cervical cancer: Diagnosis to therapy: Systematic review.
    Heliyon. 2024;10:e24398.
    PubMed    
    Abstract available

  102. CAO D, Yang Z, Dong S, Li Y, et al
    PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.
    BMC Med. 2024;22:55.
    PubMed    
    Abstract available

  103. SAEKI Y, Saito M, Irie T, Itoh F, et al
    Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
    J Med Virol. 2024;96:e29413.
    PubMed    
    Abstract available

  104. TJOKROPRAWIRO BA, Novitasari K, Saraswati W, Yuliati I, et al
    The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia.
    Gynecol Oncol Rep. 2024;51:101325.
    PubMed    
    Abstract available

  105. KARENA ZV, Faldu PS
    A Cross-Sectional Study on Knowledge, Attitude, and Practices Related to Cervical Cancer Screening Among the Nursing Staff in a Tertiary Care Hospital in the Western Region of India.
    Cureus. 2024;16:e51566.
    PubMed    
    Abstract available

  106. BARMON D, Tak A, Baruah U, Begum D, et al
    Pattern of Care of Recurrent Cervical Cancer in Low-resource Settings: Challenges and Patient-initiated Follow-up as a Novel Opportunity.
    J Midlife Health. 2023;14:205-211.
    PubMed    
    Abstract available

  107. PETRIC HOWE N, Gardiner J
    Cervical cancer could be eliminated: here's how.
    Nature. 2024 Feb 4. doi: 10.1038/d41586-024-00302.
    PubMed    


  108. CHEKRINE T, Bellefkih FZ, Hatim G, Bouchbika Z, et al
    Patterns of practice survey for cervical cancer brachytherapy in Morocco.
    Brachytherapy. 2024 Feb 3:S1538-4721(24)00008.
    PubMed    
    Abstract available

  109. LIU J, Li S, Cao Q, Zhang Y, et al
    ASO Visual Abstract: Prediction of Recurrent Cervical Cancer in 2 Years Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters-A Preliminary Study.
    Ann Surg Oncol. 2024 Feb 3. doi: 10.1245/s10434-024-14891.
    PubMed    


  110. GRIMES DR
    Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study.
    BMJ Open. 2024;14:e078551.
    PubMed    
    Abstract available

  111. HE X, Sun J, Zhang J, Zhu B, et al
    circ_0039787 promotes cervical cancer cell tumorigenesis by regulation of the miR-877-5p-KRAS axis.
    Aging (Albany NY). 2024;16.
    PubMed    
    Abstract available

  112. LI Y, Maimaitirexiati G, Wang J, Zhang J, et al
    Long non-coding RNA Linc00657 up-regulates Skp2 to promote the progression of cervical cancer through lipid reprogramming and regulation of immune microenvironment.
    Cytokine. 2024;176:156510.
    PubMed    
    Abstract available

  113. ROMELUS J, McLaughlin C, Ruggieri D, Morgan S, et al
    A Narrative Review of Cervical Cancer Screening Utilization Among Haitian Immigrant Women in the U.S.: Health Beliefs, Perceptions, and Societal Barriers and Facilitators.
    J Immigr Minor Health. 2024 Feb 3. doi: 10.1007/s10903-024-01581.
    PubMed    
    Abstract available

  114. BRIDGE F, Brotherton J, Stankovich J, Sanfilippo PG, et al
    Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
    Neurology. 2024;102:e208059.
    PubMed    
    Abstract available

  115. WANG X, Wang T, Jiang X, Ruan Y, et al
    The potential mechanism of Guizhi Fuling Wan effect in the treatment of cervical squamous cell carcinoma: A bioinformatics analysis investigation.
    Medicine (Baltimore). 2024;103:e37153.
    PubMed    
    Abstract available

  116. ALBA C, Zheng Z, Wadhera RK
    Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
    JAMA Health Forum. 2024;5:e235058.
    PubMed    
    Abstract available

  117. ZHANG N, Chen Z, Huang M, Lu Q, et al
    Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection.
    J Med Virol. 2024;96:e29451.
    PubMed    
    Abstract available

  118. ZHOU YX, Ma XH, Wang TT, Qu XL, et al
    Analysis of age-specified and genotype distribution of HPV multiple infections in the Chinese population.
    Sci Rep. 2024;14:2678.
    PubMed    
    Abstract available

  119. MITANI T, Kukimoto I, Tsukamoto T, Nomura H, et al
    A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan.
    Sci Rep. 2024;14:2632.
    PubMed    
    Abstract available

  120. BAKHSHANI A, Ganjali R, Tabatabaeizadeh SE
    Prevalence of Human Papillomavirus (HPV) Genotypes among Women During 2015-2020 in Mashhad, Iran.
    Arch Iran Med. 2023;26:419-426.
    PubMed    
    Abstract available

  121. LIU L, Fan X, Liu H, Zhang C, et al
    QUIZ: An arbitrary volumetric point matching method for medical image registration.
    Comput Med Imaging Graph. 2024;112:102336.
    PubMed    
    Abstract available

  122. FILIPAS DK, Labban M, Beatrici E, Stone BV, et al
    Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
    Vaccine. 2024;42:441-447.
    PubMed    
    Abstract available

  123. STEGMULLER T, Abbet C, Bozorgtabar B, Clarke H, et al
    Self-supervised learning-based cervical cytology for the triage of HPV-positive women in resource-limited settings and low-data regime.
    Comput Biol Med. 2024;169:107809.
    PubMed    
    Abstract available

  124. LIU S, Liu Y, Zhang H
    Minimal deviation adenocarcinoma of the cervix with lymphatic metastasis: A case report.
    Asian J Surg. 2024;47:1099-1100.
    PubMed    


  125. YABUKI A, Muraoka A, Tamauchi S, Seki T, et al
    The influence of radical trachelectomy on endometrial thickness in in vitro fertilization-embryo transfer.
    J Obstet Gynaecol Res. 2024;50:218-224.
    PubMed    
    Abstract available

  126. ZHOU X, Lin W, Qin Y, Zhang J, et al
    Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: A retrospective analysis of 369 cases.
    Cancer Cytopathol. 2024;132:119-128.
    PubMed    
    Abstract available

  127. PENG K, Tu K, Li Z, Hallinan CM, et al
    Global impacts of COVID-19 pandemic on sexual and reproductive health services: An international comparative study on primary care from the INTRePID Consortium.
    BJOG. 2024;131:508-517.
    PubMed    
    Abstract available

  128. GARCIA-ALCARAZ C, Binda A, Gordon JR, Alpert EN, et al
    Intervention recommendations to improve uptake of breast, cervical, and colorectal cancer screening among individuals living with serious mental illness.
    Cancer Causes Control. 2024;35:451-463.
    PubMed    
    Abstract available

  129. ZHANG S, Cao Y, Hu Y, Li G, et al
    Correlation Between Persistent HPV Infection and Vaginal Microecological Imbalance After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
    Altern Ther Health Med. 2024;30:414-418.
    PubMed    
    Abstract available

  130. XIAO ML, Fu L, Wei Y, Liu AE, et al
    Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma.
    Eur Radiol. 2024;34:852-862.
    PubMed    
    Abstract available

  131. ESCANDE A, Leblanc J, Hannoun-Levi JM, Renard S, et al
    Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer.
    Cancer Radiother. 2024;28:15-21.
    PubMed    
    Abstract available

  132. LUO X, Qu L, Guo Q, Song Z, et al
    Negative Instance Guided Self-Distillation Framework for Whole Slide Image Analysis.
    IEEE J Biomed Health Inform. 2024;28:964-975.
    PubMed    
    Abstract available

  133. DENIZOT A, Rousseau A
    [Intraoperative diagnosis of a tumor of the cervical spine].
    Ann Pathol. 2024;44:82-83.
    PubMed    


  134. ZHANG Q, Zhang W, Xu T, Song J, et al
    Analysis of the current state of cervical cancer prevention awareness and its influencing factors among rural women in Luohe City.
    Medicine (Baltimore). 2024;103:e35136.
    PubMed    
    Abstract available

  135. CHANUDOM I, Tharavichitkul E, Laosiritaworn W
    Prediction of Cervical Cancer Patients' Survival Period with Machine Learning Techniques.
    Healthc Inform Res. 2024;30:60-72.
    PubMed    
    Abstract available

  136. MUNGO C, Orang'o O, Ofner S, Musick B, et al
    Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
    JCO Glob Oncol. 2024;10:e2300311.
    PubMed    
    Abstract available

  137. GUO Q, Gao Y, Lin Y, Li W, et al
    A nomogram of preoperative indicators predicting lymph vascular space invasion in cervical cancer.
    Arch Gynecol Obstet. 2024 Feb 15. doi: 10.1007/s00404-024-07385.
    PubMed    
    Abstract available

  138. WANG M, Meng J, Wang H, Hu H, et al
    Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
    J Cell Mol Med. 2024;28:e18081.
    PubMed    
    Abstract available

  139. OLUBODUN T, Ogundele OO, Salisu ZA, Odusolu YO, et al
    Cervical cancer awareness and risk factors among women residing in an urban slum in Lagos, Southwest Nigeria.
    Afr Health Sci. 2023;23:269-279.
    PubMed    
    Abstract available

  140. SAMAILA A, Biambo AA, Usman N, Aliyu UM, et al
    Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals.
    Afr Health Sci. 2023;23:261-268.
    PubMed    
    Abstract available

  141. WANG W, Chen P, Yuan S
    Programmed cell death-index (PCDi) as a prognostic biomarker and predictor of drug sensitivity in cervical cancer: a machine learning-based analysis of mRNA signatures.
    J Cancer. 2024;15:1378-1396.
    PubMed    
    Abstract available

  142. HAN C, Hu C, Liu T, Sun Y, et al
    IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.
    Cell Death Dis. 2024;15:138.
    PubMed    
    Abstract available

  143. SAFARI-FARAMANI B, Safari-Faramani R, Najafi F, Zavareh DK, et al
    Socioeconomic disparities in Papanicolaou test utilization in Western Iran.
    BMC Public Health. 2024;24:471.
    PubMed    
    Abstract available

  144. GONETE TZ, Asseffa NA, Gashu KD, Tilahun B, et al
    Communicable and Non-communicable Diseases Diagnosis and Treatment Service Availability at Primary Health Care Units During COVID-19 Outbreak in Ethiopia.
    Ethiop J Health Sci. 2023;33.
    PubMed    
    Abstract available

  145. OLKHOV IG, Grishina NK, Timurzieva AB
    [The experience of organization of combined screening of uterine neck cancer in the Republic of Bashkortostan].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024;32:75-82.
    PubMed    
    Abstract available

  146. ZHANG X, Cao J, Li X, Zhang Y, et al
    Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer.
    Biochem Genet. 2024 Feb 13. doi: 10.1007/s10528-024-10728.
    PubMed    
    Abstract available

  147. CHEN Y, Sun L, Li L
    Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
    J Obstet Gynaecol. 2024;44:2311658.
    PubMed    
    Abstract available

  148. BIAN Y, Zhang Z, Deng X, Wen Q, et al
    Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
    Front Immunol. 2024;15:1357601.
    PubMed    
    Abstract available

  149. RAMLI Z, Farizan A, Tamchek N, Haron Z, et al
    Impact of Image Enhancement on the Radiomics Stability of Diffusion-Weighted MRI Images of Cervical Cancer.
    Cureus. 2024;16:e52132.
    PubMed    
    Abstract available

  150. CHO A, Kim MY, Park IS, Park CM, et al
    A retrospective study for long-term oncologic and obstetric outcomes in cervical intraepithelial neoplasia treated with loop electrosurgical excision procedure: focus on surgical margin and human papillomavirus.
    BMC Womens Health. 2024;24:116.
    PubMed    
    Abstract available

  151. ENYAN NIE, Ken-Amoah S, Tuoyire DA, Akakpo KP, et al
    HIV status and knowledge of cervical cancer among women in Ghana.
    BMC Womens Health. 2024;24:112.
    PubMed    
    Abstract available

  152. LAYET F, Murungi T, Ashaba N, Kigongo E, et al
    Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    BMC Womens Health. 2024;24:114.
    PubMed    
    Abstract available

  153. SHENG B, Pan S, Ye M, Liu H, et al
    Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis.
    Cell Death Dis. 2024;15:130.
    PubMed    
    Abstract available

  154. SETYAWATY D, Mariya S, Prabandari SA, Boilessen DR, et al
    Immunohistochemical characterization of integrin alfa 6 in uterus and cervix of the cynomolgus monkeys (Macaca fascicularis) with MfPV3 infection.
    J Med Primatol. 2024;53:e12690.
    PubMed    
    Abstract available

  155. SUN Y, Wang Y, Gan K, Wang Y, et al
    Reliable Delineation of Clinical Target Volumes for Cervical Cancer Radiotherapy on CT/MR Dual-Modality Images.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00951.
    PubMed    
    Abstract available

  156. YAN H, Huang G, Yang Z, Chen Y, et al
    Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics Model for Preoperative Predicting the Deep Stromal Invasion in Patients with Early Cervical Cancer.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00906.
    PubMed    
    Abstract available

  157. K A, B S
    A Deep Learning-Based Approach for Cervical Cancer Classification Using 3D CNN and Vision Transformer.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00911.
    PubMed    
    Abstract available

  158. DEHGHANI A, Khajepour F, Dehghani M, Razmara E, et al
    Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.
    BMC Infect Dis. 2024;24:182.
    PubMed    
    Abstract available

  159. COTTRELL-DANIELS C, Hoogland CE, Fennell BS, Simmons VN, et al
    Smoking Cessation by Cancer Treatment Status among Cervical Cancer Survivors.
    Am J Prev Med. 2024 Feb 9:S0749-3797(24)00043.
    PubMed    
    Abstract available

  160. HEYDARNIA E, Dorostgou Z, Hedayati N, Mousavi V, et al
    Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Cell Commun Signal. 2024;22:107.
    PubMed    
    Abstract available

  161. WANG Q, Zhou FY, Ding JX
    Factors associated with the persistence of human papillomavirus after surgery in patients with cervical cancer.
    Diagn Microbiol Infect Dis. 2024;108:116201.
    PubMed    
    Abstract available

  162. SERVAYGE J, Olthof EP, Mom CH, van der Aa MA, et al
    Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy.
    Cancers (Basel). 2024;16:635.
    PubMed    
    Abstract available

  163. VOGELSANG TLR, Schmoeckel E, Topalov NE, Ganster F, et al
    Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical Cancer.
    Int J Mol Sci. 2024;25:1571.
    PubMed    
    Abstract available

  164. SUCULARLI C, Simay Demir YD, Ozdemir A, Ark M, et al
    Temporal regulation of gene expression and pathways in chemotherapy-induced senescence in HeLa cervical cancer cell line.
    Biosystems. 2024;237:105140.
    PubMed    
    Abstract available

  165. ZHOU X, Li Z, Li M
    LncRNA WWTR1-AS1 upregulates Notch3 through miR-136 to increase cancer cell stemness in cervical squamous cell carcinoma.
    BMC Womens Health. 2024;24:104.
    PubMed    
    Abstract available

  166. LIU Y, Li Z
    Vaginal pH value can affect the susceptibility to human papillomavirus infection.
    BMC Infect Dis. 2024;24:176.
    PubMed    
    Abstract available

  167. BARRE-PIERREL S, Fillol F, Derhy S, Taleb S, et al
    [News in French cancer screenings].
    Rev Prat. 2024;74:40-43.
    PubMed    
    Abstract available

  168. SUN S, Yang Z, Majdaeen M, Agbele AT, et al
    Functions of Sialyltransferases in gynecological malignancies: A systematic review.
    Pathol Res Pract. 2024;254:155159.
    PubMed    
    Abstract available

  169. ZANNONI GF, Santoro A, Addante F, Cianfrini F, et al
    Endometrioid type adenocarcinoma in situ as a potential precursor lesion for extremely rare invasive endometrioid type adenocarcinoma of the cervix.
    Pathol Res Pract. 2024;254:155062.
    PubMed    
    Abstract available

  170. NILYANIMIT P, Chaithongwongwatthana S, Oranratanaphan S, Poudyal N, et al
    Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device.
    Diagn Microbiol Infect Dis. 2024;108:116160.
    PubMed    
    Abstract available

  171. ZHOU M, Su Y, Tong Y, Zhang C, et al
    Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery for the treatment of vulvar squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2023;44:103868.
    PubMed    
    Abstract available

  172. PAPOUTSIS D, Underwood M, Parry-Smith W, Tzavara C, et al
    Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia and its association with high-grade histopathological recurrence after cervical excision in women with negative excision margins: a systematic review and meta-analysis.
    Arch Gynecol Obstet. 2024;309:939-948.
    PubMed    
    Abstract available

  173. EL-LATEEF AEA, El-Shemi AGA, Hassanein RAM, Iqbal MS, et al
    Analysis of Correlation Between LncRNA TDRG1 Expression and its Prognosis in Cervical Carcinoma Tissues.
    Appl Biochem Biotechnol. 2024;196:1079-1088.
    PubMed    
    Abstract available

  174. ROSENDO-CHALMA P, Antonio-Vejar V, Ortiz Tejedor JG, Ortiz Segarra J, et al
    The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.
    Biology (Basel). 2024;13:77.
    PubMed    
    Abstract available

  175. GREENMAN M, McNamara B, Mutlu L, Santin AD, et al
    Targeting cervical cancer with anti-PD-1 antibodies: what's new?
    Expert Opin Biol Ther. 2024 Feb 23. doi: 10.1080/14712598.2024.2323596.
    PubMed    


  176. FONG AMARIS WM, de Assumpcao PP, Valadares LJ, Moreira FC, et al
    Microbiota changes: the unseen players in cervical cancer progression.
    Front Microbiol. 2024;15:1352778.
    PubMed    
    Abstract available

  177. YOO JG, Lee SJ, Nam EJ, No JH, et al
    Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.
    J Gynecol Oncol. 2024 Feb 13. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  178. GAO F, Qian T, Sun M, Lu Y, et al
    MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
    Curr Med Imaging. 2024;20:1-8.
    PubMed    
    Abstract available

  179. LIU Q, Sun YX, Liu KJ, Li PQ, et al
    [Oncological outcomes of laparoscopic radical trachelectomy for early stage cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:135-142.
    PubMed    
    Abstract available

  180. NDARUKWA S, Flores JA, Rosenblatt E, Berger D, et al
    Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients With Cervical Cancer and Impact on IGBT Implementation-An IAEA Study.
    JCO Glob Oncol. 2024;10:e2300336.
    PubMed    
    Abstract available

  181. INGAMELLS S, Bell R, Nip J, Innes C, et al
    Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
    N Z Med J. 2024;137:57-76.
    PubMed    
    Abstract available


  182. News Brief: A quarter of U.S. women are not up to date on cervical cancer screening.
    Am J Nurs. 2024;124:11.
    PubMed    


  183. GE J, Weng C, Zhao J, Yuan D, et al
    Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report.
    Front Cardiovasc Med. 2024;11:1351358.
    PubMed    
    Abstract available

  184. ZHANG H, Zhang R, Zhang G, Liu W, et al
    [Retracted] Clinical significance of miR?1298 in cervical cancer and its biological function in vitro.
    Oncol Lett. 2024;27:150.
    PubMed    
    Abstract available

  185. YADAV R, Chauhan MB, Yadav C, Ranga S, et al
    Awareness data on cervical cancer among females of rural and urban areas of Haryana, India.
    Data Brief. 2024;53:110168.
    PubMed    
    Abstract available

  186. ZHENG H, Liu M, Shi S, Huang H, et al
    MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFbeta2-Smad2/3 signaling pathway in cervical cancer.
    Mol Oncol. 2024 Feb 21. doi: 10.1002/1878-0261.13613.
    PubMed    
    Abstract available

  187. CHEN X, Dong X, Li H, Wu T, et al
    RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
    Cancer Cell Int. 2024;24:80.
    PubMed    
    Abstract available

  188. PERKINS RB, Fuzzell L, Lake P, Brownstein NC, et al
    Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
    Womens Health Issues. 2024 Feb 20:S1049-3867(24)00001.
    PubMed    
    Abstract available

  189. FOGH JORGENSEN S, Kellen E, Haelens A, Herck KV, et al
    How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes.
    J Med Screen. 2024 Feb 21:9691413241231440. doi: 10.1177/09691413241231440.
    PubMed    
    Abstract available

  190. ZOU Q, Wu Y, Zhang S, Li S, et al
    Escherichia coli and HPV16 coinfection may contribute to the development of cervical cancer.
    Virulence. 2024;15:2319962.
    PubMed    
    Abstract available

  191. SHAFFI AF, Odongo EB, Itsura PM, Tonui PK, et al
    Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in Kenya.
    Gynecol Oncol Rep. 2024;51:101331.
    PubMed    
    Abstract available

  192. HAMID HA, Lin X, Qin YK, Akim AM, et al
    Best practices for managing malodorous and infected wounds in advanced cervical cancer.
    Int Wound J. 2024;21:e14574.
    PubMed    
    Abstract available

  193. MANTULA F, Toefy Y, Sewram V
    Barriers to cervical cancer screening in Africa: a systematic review.
    BMC Public Health. 2024;24:525.
    PubMed    
    Abstract available

  194. LU Y, Wu Q, Wang L, Ji L, et al
    Chlamydia trachomatis enhances HPV persistence through immune modulation.
    BMC Infect Dis. 2024;24:229.
    PubMed    
    Abstract available

  195. WANG Z, Liu C, Liu W, Lv X, et al
    Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines.
    BMC Genomics. 2024;25:198.
    PubMed    
    Abstract available

  196. ZHANG J, Qiu H, Qing Y, Hu Y, et al
    A commentary on "Local excision as a viable alternative to c-stage cervical cancer in women of reproductive age: a population-based cohort study".
    Int J Surg. 2024 Feb 21. doi: 10.1097/JS9.0000000000001218.
    PubMed    


  197. MINGOLA P, Alshomrani A, Greiner T
    Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
    J Hematop. 2024;17:23-26.
    PubMed    
    Abstract available

  198. PAUL A, Dutta P, Basu K
    Assessment and clinicopathological correlation of p16 expression in cervical squamous cell carcinoma of Indian population: Diagnostic implications.
    J Cancer Res Ther. 2023;19:2012-2017.
    PubMed    
    Abstract available

  199. DATKHILE KD, Patil SR, Patil MN, Durgawale PP, et al
    Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    J Cancer Res Ther. 2023;19:1925-1930.
    PubMed    
    Abstract available

  200. AZAK C, Kavak G, Ertan F, Alioglu F, et al
    The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
    J Cancer Res Ther. 2023;19:1825-1830.
    PubMed    
    Abstract available

  201. PURI I, Sharma R, Dewan D, Angurana S, et al
    Sexual function status after adjuvant radiation including vaginal cuff brachytherapy in survivors of cancer cervix.
    J Cancer Res Ther. 2023;19:1721-1724.
    PubMed    
    Abstract available

  202. ASHOK G, Basu S, Priyamvada P, Anbarasu A, et al
    Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
    Rev Med Virol. 2024;34:e2524.
    PubMed    
    Abstract available

  203. CHEN Y, Chen S, Chen K, Ji L, et al
    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways.
    Chin Herb Med. 2023;16:94-105.
    PubMed    
    Abstract available

  204. DURA MC, Akturk H, Aslan O, Yildiz S, et al
    Human Papillomavirus Infection (HPV) Prevalence in the Black Sea Region of Turkey: Primary HPV Screening for Cervical Cancer.
    Cureus. 2024;16:e52615.
    PubMed    
    Abstract available

  205. G SN, Sssn R, Chaturvedula L, Adole P, et al
    Deoxyribose Nucleic Acid Damage and Its Association With Plasma Malondialdehyde Levels Among Patients With Cervical Cancer: A Case-Control Study.
    Cureus. 2024;16:e52600.
    PubMed    
    Abstract available

  206. CAO Y, Xiong J, Du Y, Tang Y, et al
    Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
    Lasers Med Sci. 2024;39:68.
    PubMed    
    Abstract available

  207. TESFAYE E, Kumbi B, Mandefro B, Hemba Y, et al
    Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Sci Rep. 2024;14:4053.
    PubMed    
    Abstract available

  208. OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al
    Improving cancer incidence evaluation through local government area matching: a study of the Edo-Benin cancer registry in Nigeria.
    BMC Public Health. 2024;24:514.
    PubMed    
    Abstract available

  209. SUKRONG M, Prapaisilp P, Juntamongkol T, Siranart N, et al
    Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.
    BMC Womens Health. 2024;24:129.
    PubMed    
    Abstract available

  210. PRETI M, Boldorini R, Gallio N, Cavagnetto C, et al
    Human papillomavirus genotyping in high-grade vaginal intraepithelial neoplasia: A multicentric Italian study.
    J Med Virol. 2024;96:e29474.
    PubMed    
    Abstract available

  211. ZHOU X, Wang Y, Bao M, Chu Y, et al
    Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers.
    Appl Microbiol Biotechnol. 2024;108:221.
    PubMed    
    Abstract available

  212. WANG YY, Ye LH, Zhao AQ, Gao WR, et al
    M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.
    Cancer Biol Ther. 2024;25:2306674.
    PubMed    
    Abstract available

  213. BAEKER BISPO JA, Goo I, Ashad-Bishop K, Kobetz E, et al
    Does Neighborhood Social Cohesion Influence Participation in Routine Cancer Screening? Findings From a Representative Sample of Adults in South Florida.
    Fam Community Health. 2024;47:130-140.
    PubMed    
    Abstract available

  214. STEFANOS R, Lewis RM, Querec TD, Gargano JW, et al
    High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
    Hum Vaccin Immunother. 2024;20:2308378.
    PubMed    
    Abstract available

  215. MITOMA T, Maki J, Ooba H, Ogawa C, et al
    Association of Regular Cervical Cancer Screening with Socioeconomic, COVID-19 Infection and Vaccine Status Among Japanese Population: Cohort Observational Study.
    Int J Gen Med. 2024;17:541-551.
    PubMed    
    Abstract available

  216. WU F, Zhang R, Li F, Qin X, et al
    Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.
    Front Med (Lausanne). 2024;11:1336640.
    PubMed    
    Abstract available

  217. AKINNIBOSUN O, Abakpa OG, Ujoh AJ, Oche DA, et al
    Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria.
    Ethiop J Health Sci. 2024;34:15-26.
    PubMed    
    Abstract available

  218. CARMACK C, Roncancio A, Coleman TM, McKay S, et al
    Concept mapping sociocultural aspects of cervical cancer prevention among African American women.
    Front Public Health. 2024;11:1311286.
    PubMed    
    Abstract available

  219. GUO S, Chen P, Yang Y, Wei W, et al
    Tumor-to-stroma cd8(+) t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:93.
    PubMed    
    Abstract available

  220. LUO L, Wang M, Li X, Luo C, et al
    Correction: A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression.
    Cancer Cell Int. 2024;24:76.
    PubMed    



  221. Correction to: Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2024 Feb 15:hyae023. doi: 10.1093.
    PubMed    


  222. MICHA JP, Rettenmaier MA, Bohart RD, Goldstein BH, et al
    Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
    J Robot Surg. 2024;18:80.
    PubMed    
    Abstract available

  223. WANG T, Li YY, Ma NN, Wang PA, et al
    A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer.
    World J Surg Oncol. 2024;22:55.
    PubMed    
    Abstract available

  224. EKAWATI FM, Listiani P, Idaiani S, Thobari JA, et al
    Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
    BMC Womens Health. 2024;24:125.
    PubMed    
    Abstract available

  225. FOKOM-DEFO V, Dille I, Fokom-Domgue J
    Single dose HPV vaccine in achieving global cervical cancer elimination.
    Lancet Glob Health. 2024;12:e360-e361.
    PubMed    


  226. JORGENSEN KA, Agusti N, Wu CF, Kanbergs A, et al
    Fertility-sparing surgery versus standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
    Am J Obstet Gynecol. 2024 Feb 14:S0002-9378(24)00084.
    PubMed    
    Abstract available

  227. KUZUCULAR E, Ozden F, Muezzinoglu B
    Comparison of liquid-based cytology and cell blocks prepared from cell remnants for diagnosis of cervical pathology.
    Ann Diagn Pathol. 2024;69:152265.
    PubMed    
    Abstract available

  228. KAUR JAWANDA I, Soni T, Kumari S, Prabha V, et al
    Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases: empowering precision medicine in gynecology.
    Biomarkers. 2024;29:7-17.
    PubMed    
    Abstract available

  229. PEITZ JG, Adebamowo CA, Adebamowo SN
    Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
    J Nutr. 2024;154:583-589.
    PubMed    
    Abstract available

  230. MASUDA M, Iida K, Iwabuchi S, Tanaka M, et al
    Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
    Am J Pathol. 2024;194:415-429.
    PubMed    
    Abstract available

  231. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Public Health. 2024;227:42-48.
    PubMed    
    Abstract available

  232. PARKER SL, Amboree TL, Bulsara S, Daheri M, et al
    Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
    Am J Prev Med. 2024;66:540-547.
    PubMed    
    Abstract available

  233. YUILL S, Egger S, Smith MA, Velentzis L, et al
    Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.
    J Med Screen. 2024;31:35-45.
    PubMed    
    Abstract available

  234. GIRIJA NS, Neethi B, Sakthimanipriya L, Sinekha MA, et al
    In-Vitro Cytotoxic, Antiproliferative and Apoptotic Activity of Siddha Formulation Nandhi Mezhugu (NM) Against Hela Cell Line.
    Appl Biochem Biotechnol. 2024;196:1612-1622.
    PubMed    
    Abstract available

  235. SOOKAROMDEE P, Wiwanitkit V
    Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
    J Cancer Res Ther. 2023;19.
    PubMed    


  236. AKRAM M, Khazir M, Khan M, Afrose R, et al
    Age-wise cancer incidence in western Uttar Pradesh in India: An observational study.
    J Cancer Res Ther. 2023;19.
    PubMed    
    Abstract available

  237. LINDROTH Y, Pedersen L, Alssamaray J, Berglund T, et al
    Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
    Acta Obstet Gynecol Scand. 2024;103:378-386.
    PubMed    
    Abstract available

  238. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    PubMed    
    Abstract available

  239. KNISELY A, Ahmed J, Stephen B, Piha-Paul SA, et al
    Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
    Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
    PubMed    
    Abstract available

  240. LOU H, Cai H, Huang X, Li G, et al
    Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
    Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
    PubMed    
    Abstract available

  241. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
    An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
    Eur J Cancer. 2024;201:113915.
    PubMed    
    Abstract available

  242. WU J, Wang R, Chen W, Wu Y, et al
    Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:210-216.
    PubMed    
    Abstract available

  243. DORISMOND VG, Saraiya M, Gopalani SV, Soman A, et al
    Variation in cervical cancer screening test utilization and results in a United States-based program.
    Gynecol Oncol. 2024;184:96-102.
    PubMed    
    Abstract available

  244. BEFANO B, Wentzensen N, Lorey T, Poitras N, et al
    Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
    Gynecol Oncol. 2024;184:89-95.
    PubMed    
    Abstract available

  245. KUCERA CW, Chappell NP, Tian C, Richardson MT, et al
    Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
    Gynecol Oncol. 2024;184:224-235.
    PubMed    
    Abstract available

  246. DINICU AI, Dioun S, Wang Y, Huang Y, et al
    Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
    Gynecol Oncol. 2024;184:214-223.
    PubMed    
    Abstract available

  247. ROOF KA, Wichmann HK, Carlton LJ, Nguyen ML, et al
    Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy.
    Gynecol Oncol. 2024;185:46-50.
    PubMed    
    Abstract available

  248. NASIOUDIS D, Gysler S, Latif N, Cory L, et al
    Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
    Gynecol Oncol. 2023;180:1-5.
    PubMed    
    Abstract available

  249. XU JY, Hu M, Wu SG, Zhou J, et al
    Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
    Int J Gynaecol Obstet. 2024;164:1053-1063.
    PubMed    
    Abstract available

  250. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
    Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
    Int J Gynaecol Obstet. 2024;164:951-958.
    PubMed    
    Abstract available

  251. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    PubMed    
    Abstract available

  252. FIELDS EC, Erickson B, Hubbard A, Chino J, et al
    Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142.
    Int J Radiat Oncol Biol Phys. 2024;118:869.
    PubMed    


  253. MEI X, Kok HP, Rodermond HM, van Bochove GGW, et al
    Radiosensitization by Hyperthermia Critically Depends on the Time Interval.
    Int J Radiat Oncol Biol Phys. 2024;118:817-828.
    PubMed    
    Abstract available

  254. SHI C, Zhang Z
    [Retracted] MicroRNA?362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2024;51:54.
    PubMed    
    Abstract available

  255. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
    Sociodemographic characteristics and their association with survival in women with cervical cancer.
    BMC Cancer. 2024;24:161.
    PubMed    
    Abstract available

  256. LIU H, Cui Y, Chang C, Zhou Z, et al
    Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
    BMC Cancer. 2024;24:150.
    PubMed    
    Abstract available

  257. XIAO L, Dong X, Sun J, Zhang X, et al
    Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
    BMC Cancer. 2024;24:169.
    PubMed    
    Abstract available

  258. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
    BMC Cancer. 2024;24:217.
    PubMed    
    Abstract available

  259. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    PubMed    
    Abstract available

  260. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    PubMed    


  261. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    PubMed    
    Abstract available

  262. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    PubMed    
    Abstract available

  263. MANGENAH C, Sibanda EL, Maringwa G, Sithole J, et al
    Provider and female client economic costs of integrated sexual and reproductive health and HIV services in Zimbabwe.
    PLoS One. 2024;19:e0291082.
    PubMed    
    Abstract available

  264. MUNSHI RM
    Correction: Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0298980.
    PubMed    
    Abstract available

  265. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;